Welcome to our dedicated page for XMax news (Ticker: XWIN), a resource for investors and traders seeking the latest updates and insights on XMax stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect XMax's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of XMax's position in the market.
XMax (NASDAQ: XWIN) announced on November 26, 2025 that its indirectly wholly owned subsidiary invested approximately US$5.60 million to subscribe to a 99.82% interest in Preamble Capital I, a series of CGF2021 LLC.
On November 24, 2025, Preamble Capital I completed acquisition of a 39.7% interest in a fund that holds 55,629 Class A and 3,781 Class C shares of Space Exploration Technologies Corp. (SpaceX).
XMax (NASDAQ: XWIN) announced a US$5,000,000 convertible promissory note issued to Billiongold Holding Limited on November 18, 2025. The note matures 36 months after funding, bears interest at 6% per annum, and is convertible at the holder's option into common stock at US$7.80 per share any time before full repayment. The financing was completed in a transaction exempt from registration under Regulation S of the U.S. Securities Act of 1933.
This provides near-term liquidity while creating potential share issuance if the holder converts the note.